Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KPTI Karyopharm Therapeutics Inc.

盘前交易 02-19 05:20:05 EST

9.25

-0.15

-1.60%

最高9.82	最低9.14	成交量75.46万
今开9.64	昨收9.40	日振幅7.25%
总市值1.69亿	流通市值1.48亿	总股本1,831万
成交额706.84万	换手率4.72%	流通股本1,600万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KPTI","market":"US","secType":"STK","nameCN":"Karyopharm Therapeutics Inc.","latestPrice":9.25,"timestamp":1771448400000,"preClose":9.4,"halted":0,"volume":754572,"delay":0,"changeRate":-0.015957446808510675,"floatShares":16000500,"shares":18310300,"eps":-17.93,"marketStatus":"盘前交易","change":-0.15,"latestTime":"02-19 05:20:05 EST","open":9.64,"high":9.8199,"low":9.1383,"amount":7068411.70854,"amplitude":0.072511,"askPrice":9.99,"askSize":20,"bidPrice":8.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-17.93,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771511400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1383714000000,"exchange":"NASDAQ","adjPreClose":9.25,"postHourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.25,"latestTime":"19:16 EST","volume":3735,"amount":34544.6776,"timestamp":1771460198265,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5567616340335062,"impliedVol":3.2646,"impliedVolPercentile":0.9759},"requestUrl":"/m/hq/s/KPTI","defaultTab":"news","newsList":[{"id":"1182268638","title":"Karyopharm公布2025年初步未经审计营收 并重申2026年有望发布变革性三期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1182268638","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182268638?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:02","pubTimestamp":1768219354,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc.今日披露了2025财年初步未经审计的营收预期，同时再度确认其核心研发管线将在2026年迎来关键节点。公司强调，届时公布的三期临床试验数据可能成为颠覆现有治疗格局的里程碑。尽管具体财务细节尚未完全公开，但此次预告凸显了公司对商业化进程与研发突破双线并进的战略信心。在生物技术板块波动加剧的背景下，Karyopharm通过明确时间表向投资者传递确定性。分析师指出，若三期数据符合预期，该企业有望在靶向治疗领域构建差异化竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"1149622364","title":"Karyopharm Therapeutics公布依据纳斯达克上市规则5635(C)(4)授予的引援股权奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1149622364","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149622364?lang=zh_cn&edition=full","pubTime":"2026-01-03 06:25","pubTimestamp":1767392727,"startTime":"0","endTime":"0","summary":"1月2日——Karyopharm Therapeutics Inc宣布，公司已根据纳斯达克上市规则5635(C)(4)条款，向新入职员工授予了引援性股权激励。该举措旨在吸引高端人才加入企业团队，通过股权授予方式强化人才与企业发展的深度绑定。此次股权授予完全遵循纳斯达克相关监管要求，体现了公司治理的规范性与透明度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"1170067306","title":"Karyopharm Therapeutics公布根据纳斯达克上市规则5635(C)(4)的激励授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1170067306","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170067306?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:31","pubTimestamp":1763569862,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc：*KARYOPHARM THERAPEUTICS公布根据纳斯达克上市规则5635(C)(4)的激励授予。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"1102548974","title":"Karyopharm Therapeutics 第三季度净收入为负3312.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102548974","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102548974?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:28","pubTimestamp":1763569688,"startTime":"0","endTime":"0","summary":"11月3日 - Karyopharm Therapeutics 第三季度产品收入为3203.2万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2582861877","title":"Karyopharm Therapeutics Inc.2025财年第三财季实现净利润-33.13百万美元，同比减少3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861877","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861877?lang=zh_cn&edition=full","pubTime":"2025-11-09 00:01","pubTimestamp":1762617688,"startTime":"0","endTime":"0","summary":"11月9日，Karyopharm Therapeutics Inc.公布财报，公告显示公司2025财年第三财季净利润为-33.13百万美元，同比减少3.31%；其中营业收入为44.04百万美元，同比增加13.56%，每股基本收益为-3.82美元。机构评级：截至2025年11月9日，当前有7家机构对Karyopharm Therapeutics Inc.目标价做出预测，其中目标均价为14.00美元，其中最低目标价为6.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109000148975cc214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109000148975cc214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2581703588","title":"Karyopharm Therapeutics Inc.盘中异动 临近收盘股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581703588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581703588?lang=zh_cn&edition=full","pubTime":"2025-11-06 04:50","pubTimestamp":1762375830,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.股票出现异动，股价大幅下挫5.54%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。消息层面，截至04时50分，《加皇资本市场维持Karyopharm Therapeutics买入评级，目标价19美元》资讯为影响Karyopharm Therapeutics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","KPTI","LENZ","BK4539"],"gpt_icon":0},{"id":"1145943738","title":"Karyopharm Therapeutics Inc：Jefferies将目标价从4.5美元上调至15美元以反映反向股票拆分","url":"https://stock-news.laohu8.com/highlight/detail?id=1145943738","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145943738?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:29","pubTimestamp":1762262973,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc：Jefferies将目标价从4.5美元上调至15美元以反映反向股票拆分","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"1138346110","title":"Karyopharm Therapeutics 提交高达 957 万股普通股的转售招股说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1138346110","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138346110?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:17","pubTimestamp":1762204639,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics 提交高达 957 万股普通股的转售招股说明书。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2574971100","title":"Karyopharm Therapeutics Inc.股价重挫19.76% 市值跌793.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574971100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574971100?lang=zh_cn&edition=full","pubTime":"2025-10-08 21:32","pubTimestamp":1759930326,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日21时32分，Karyopharm Therapeutics Inc.股票出现异动，股价快速跳水19.76%。截至发稿，该股报4.63美元/股，成交量106.831万股，换手率12.32%，振幅3.29%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008213207a6b0cda2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008213207a6b0cda2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","KPTI"],"gpt_icon":0},{"id":"1190144660","title":"Karyopharm Therapeutics Inc预计将继续探索潜在融资和战略替代方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1190144660","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190144660?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:04","pubTimestamp":1759921477,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc表示，公司预计将继续探索潜在的融资机会和战略替代方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"1164227109","title":"Karyopharm Therapeutics：预计2025年第三季度总收入及美国Xpovio净产品收入分别为4200万至4400万美元和约3200万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164227109","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164227109?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:04","pubTimestamp":1759921465,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics公布，预计2025年第三季度总收入将在4200万美元至4400万美元区间内，美国Xpovio净产品收入预计约为3200万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"1177101561","title":"Karyopharm Therapeutics Inc.骨髓纤维化III期Sentry试验顶线数据预计2026年3月发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1177101561","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177101561?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:03","pubTimestamp":1759921432,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc.宣布，其针对骨髓纤维化适应症的III期Sentry临床试验进展顺利，顶线数据预计将于2026年3月按计划公布。\n该项关键性试验旨在评估公司核心药物在治疗骨髓纤维化患者中的疗效和安全性。骨髓纤维化是一种罕见的血液肿瘤疾病，目前治疗选择有限，患者迫切需要新的治疗方案。\n试验数据的如期发布将为公司后续的监管申请和商业化进程奠定重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"1148139903","title":"Karyopharm宣布战略融资交易以支持业务增长；将现金使用期延长至2026年第二季度，超越骨髓纤维化Phase 3 Sentry试验预期顶线数据公布时间","url":"https://stock-news.laohu8.com/highlight/detail?id=1148139903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148139903?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:03","pubTimestamp":1759921417,"startTime":"0","endTime":"0","summary":"Karyopharm宣布战略融资交易以支持业务增长；将现金使用期延长至2026年第二季度，超越骨髓纤维化Phase 3 Sentry试验预期顶线数据公布时间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"1153292168","title":"Karyopharm Therapeutics Inc.：交易为公司带来1亿美元财务灵活性和追加资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1153292168","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153292168?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:03","pubTimestamp":1759921400,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc.：相关交易为Karyopharm提供1亿美元的财务灵活性和追加资本支持","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2518822073","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨5.22%报7.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518822073?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:19","pubTimestamp":1741616363,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时19分，Karyopharm Therapeutics Inc.股票出现波动，股价快速上涨5.22%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221923abf30e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221923abf30e51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ"],"gpt_icon":0},{"id":"2517944041","title":"Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517944041?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:43","pubTimestamp":1741193017,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时43分，Karyopharm Therapeutics Inc.股票出现异动，股价大幅跳水5.20%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004337989d6422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004337989d6422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2516658033","title":"Karyopharm Therapeutics Inc.盘中异动 快速下跌5.09%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658033?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017185,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Karyopharm Therapeutics Inc.股票出现异动，股价急速跳水5.09%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353069637c0fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353069637c0fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ"],"gpt_icon":0},{"id":"2516335036","title":"Baird：维持Karyopharm Therapeutics(KPTI.US)评级，由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516335036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516335036?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:51","pubTimestamp":1741006293,"startTime":"0","endTime":"0","summary":"Baird：维持Karyopharm Therapeutics(KPTI.US)评级，由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03205148492763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2516371793","title":"Karyopharm Therapeutics Inc.盘中异动 临近午盘急速下挫5.15%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516371793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516371793?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:46","pubTimestamp":1740761178,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时46分，Karyopharm Therapeutics Inc.股票出现波动，股价大幅下跌5.15%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100461898969801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100461898969801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2514387366","title":"Karyopharm Therapeutics Inc.盘中异动 早盘大幅上涨5.49%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387366?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:14","pubTimestamp":1740672884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时14分，Karyopharm Therapeutics Inc.股票出现异动，股价快速上涨5.49%。截至发稿，该股报10.37美元/股，成交量10.3353万股，换手率1.23%，振幅9.36%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228001444a25693d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228001444a25693d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.karyopharm.com","stockEarnings":[{"period":"1week","weight":0.2551},{"period":"1month","weight":0.4659},{"period":"3month","weight":0.6059},{"period":"6month","weight":0.4683},{"period":"1year","weight":-0.0212},{"period":"ytd","weight":0.2568}],"compareEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1223},{"period":"ytd","weight":0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司，专注于发现和开发针对核转运靶点的新型一线药物，用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.016},{"month":2,"riseRate":0.615385,"avgChangeRate":0.052024},{"month":3,"riseRate":0.583333,"avgChangeRate":0.056308},{"month":4,"riseRate":0.25,"avgChangeRate":-0.030056},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.043558},{"month":6,"riseRate":0.583333,"avgChangeRate":0.012026},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.027059},{"month":8,"riseRate":0.5,"avgChangeRate":0.051463},{"month":9,"riseRate":0.5,"avgChangeRate":-0.016173},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.041145},{"month":11,"riseRate":0.666667,"avgChangeRate":0.126143},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.06783}],"exchange":"NASDAQ","name":"Karyopharm Therapeutics Inc.","nameEN":"Karyopharm Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Karyopharm Therapeutics Inc.,KPTI,Karyopharm Therapeutics Inc.股票,Karyopharm Therapeutics Inc.股票老虎,Karyopharm Therapeutics Inc.股票老虎国际,Karyopharm Therapeutics Inc.行情,Karyopharm Therapeutics Inc.股票行情,Karyopharm Therapeutics Inc.股价,Karyopharm Therapeutics Inc.股市,Karyopharm Therapeutics Inc.股票价格,Karyopharm Therapeutics Inc.股票交易,Karyopharm Therapeutics Inc.股票购买,Karyopharm Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}